跳至主要内容
临床试验/PACTR202302648824229
PACTR202302648824229已完成未知

Evaluating the efficacy of local corticosteroid injection, platelet-rich plasma, and Extracorporeal shockwave therapy in patients with Pes Anserine bursitis

Al Azhar University0 个研究点目标入组 180 人开始时间: 2022年10月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Patients are clinically diagnosed with chronic pes anserine bursitis by a rheumatologist based on Larson and Baum's criteria:
  • - Pain in the anteromedial area of the knee, especially when moving uphill or downstairs
  • - Morning discomfort and stiffness lasting more than an hour
  • - Nocturnal pain; and difficulty rising from a chair or getting out of a car.
  • - Resistant to traditional treatments such as NSAIDs and Physiotherapy.

排除标准

  • - blood disorders
  • - pacemakers
  • - paresis of lower limbs
  • - active malignancy or infection
  • - pregnancy
  • - fractures
  • - having undergone knee surgery
  • - Patients who declined to participate in the trial
  • - those allergic to corticosteroid injections,
  • - those suffering from fibromyalgia

研究者

相似试验